Clinical Trial Update: Clinical Trial Evaluating Lumateperone Monotherapy in the Treatment of Bipolar Depression or Major Depressive Disorder [Phase 3]

View source ↗

Summary

Clinical trial update reports completion of a Phase 3 study evaluating lumateperone as monotherapy in bipolar depression and major depressive disorder, with res…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Disorder
• Major Depressive Disorder

Drugs mentioned

• Lumateperone (lumateperone)

Snippet

Sponsor: Intra-Cellular Therapies, Inc. | Conditions: Bipolar Depression, Major Depressive Disorder | Phase 3 | Status: COMPLETED | Results posted: 2025-03-19